Imstem Biotechnology is a biotechnology company focusing on developing cell therapeutic products derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular, blood system diseases, and autoimmune diseases.

Biotechnology

ImStem Biotechnology

ImStem Biotechnology's headquarters in Farmington, CT, United States

Michael Men

Edmund Mickunas

Richard Kim

Xiaofang Wang

Renhe Xu

Jeffery Cohen

Joel S. Pachter

Qilong Ying

Hongkui Deng

Rudolf Jaenisch

David Benjamin Turitz Cox

Troy Lund

The Scientific Advisory team at ImStem Biotechnology provides expert guidance on the development and application of cell therapeutic products derived from human pluripotent stem cells. They ensure scientific rigor, offer strategic insights, and assist in navigating regulatory pathways to optimize treatments for neural, heart, vascular, blood system, and autoimmune diseases.

Scientific Advisory

The Leadership Team at ImStem Biotechnology is responsible for setting the strategic vision and direction of the company, overseeing the development and commercialization of innovative stem cell-based therapies. Comprising the CEO, CMO, and CTO, the team collaborates to drive research initiatives, ensure regulatory compliance, and foster partnerships, while also guiding the organization towards achieving its mission of advancing health solutions for neural, cardiac, vascular, and autoimmune conditions.

Leadership Team

This department focuses on conducting and overseeing clinical trials and research studies to advance medical knowledge and patient care.

ImStem Biotechnology

Org chart

Board & advisors

Teams

Scientific Advisory

Leadership Team

Clinical Research

Offices

ImStem Biotechnology

Org chart

Board & advisors

Teams

Scientific Advisory

Leadership Team

Clinical Research

Offices

Related companies